PRA launches pediatric site network
PRA Health Sciences has launched a new site network focused on improving pediatric clinical development and access to novel medicines in this special patient population.
Archives for November 28, 2018
Evotec and Immuneering bring iPSC, AI tech together in research tie-up
Evotec and Immuneering are combining iPSC and AI technologies through a research collaboration to discover novel small molecules for rare hereditary metabolic diseases.
GW: Inventory and capacity set for ‘even the most aggressive of demand forecast’
GW Pharma has told investors its capacity is “more than sufficient” to meet launch requirements in Europe next year, where the firm’s CBD medicine Epidiolex is under review.
NEWS IN BRIEF
J&J receives fresh blow to protect Zytiga against generic entry
US Court of Appeals knocked down J&J’s efforts to block manufacturers producing generic versions of its product, Zytiga.
CTTI’s new recommendations target investigator qualification
The new recommendations look to provide a more efficient and effective means of qualifying clinical trial investigators – to help teams ‘conduct better, more efficient clinical trials,’ says CTTI exec.
Mylan NDEA contamination prompts Teva recall in US
Teva is the latest firm to recall valsartan products after a probable carcinogen was detected in its supplier’s API.
Bayer taps AI technologies in drug discovery collaboration
Cyclica, a Bayer G4A company, will work with Bayer to advance drug discovery. The collaboration will involve looking further into polypharmacological profiles of small molecules.
Janssen: ‘There’s too much at stake to settle for doing things the way we’ve always done them’
The industry must be “relentless” in driving the adoption of new advances in technology, says Janssen, which has shifted from doing things for patients and investigators, to doing things with them.